Showing results (1231-1240 of 2,583) with videos related to
Sort By:
Pageof 259
Molecular Oncology|October 19, 2024
Combined spatially resolved metabolomics and spatial transcriptomics reveal the mechanism of RACK1-mediated fatty acid synthesisLixiu Xu, Jinqiu Li, Junqi Ma, et al.Molecular Oncology|May 29, 2026
Flow Enabled Target Capture Halbach-based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patientsMichiel Stevens, Anouk Mentink, Tom Niessink, et al.Molecular Oncology|May 22, 2026
Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr-mutated lung cancerJun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, et al.Molecular Oncology|May 27, 2026
A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose-driven glioblastomaPatryk Rurka, Wioleta Cieślik, Wojciech Płaziński, et al.Molecular Oncology|March 2, 2026
Subtype-specific enhancer RNAs define transcriptional regulators and prognosis in breast cancersAamena Y Patel, Peyman Zarrineh, Nathnael T Tuffa, et al.Molecular Oncology|February 24, 2026
Interrogating the immune landscape of microsatellite stable RAS-mutated colon cancerRodrigo Dienstmann, Eduardo García-Galea, Alice O'Farrell, et al.Molecular Oncology|April 20, 2026
CD47 promotes mitogen-activated protein kinase and epithelial-to-mesenchymal transition molecular programs to drive prometastatic phenotypes in non-small cell lung cancerAsa P Y Lau, Lilian G Zhai, Ryunosuke Hoshi, et al.Molecular Oncology|March 25, 2026
Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activationCarolina Punziano, Giuseppina Minopoli, Simona Romano, et al.Molecular Oncology|March 26, 2026
Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patientsStefan Werner, Pierre Tennstedt, Randi C Pose, et al.Molecular Oncology|May 27, 2026
ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept studyDimitra Stergiopoulou, Athina Markou, Eleonora Nicolo, et al.Pageof 259